BioCentury
ARTICLE | Clinical News

Xarano ethacrynate sodium to prevent increased intraocular pressure: Completed patient enrollment in a Phase III trial, which should be completed in the second

June 12, 1995 7:00 AM UTC

Telor Ophthalmic Pharmaceuticals Inc. (TELR), Wilmington, Mass. Product: Xarano ethacrynate sodium to prevent increased intraocular pressure Indication: Cataract surgery Status: Completed patient enro...